Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections such as Mounjaro (tirzepatide) and Wegovy (semaglutide) are given as subcutaneous injections (meaning just beneath the skin, not into a muscle) at one of three sites: the abdomen, the thigh, or the upper arm. Choosing between those sites is the first real decision you'll face once treatment begins, and it is more straightforward than most people expect. These are prescription-only medicines, so a GPhC-registered prescriber assesses your suitability before any treatment starts; the injection technique itself is covered in the Patient Information Leaflet supplied with your pen, and our clinical team is available seven days a week if questions come up once you're treating. For a fuller picture of what treatment involves from the start, the weight loss injection overview is a good place to begin.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
All three approved injection sites (abdomen, thigh, and upper arm) deliver the medicine reliably. The fatty tissue just beneath the skin at each of these locations absorbs the drug in the same way, so no single site produces stronger results than another. What differs is ease of access.
The abdomen (anywhere on the tummy except the area within about 5 cm of the navel) is where most people begin. You can see exactly what you're doing, pinch a fold of skin comfortably, and reach the site without assistance. The thigh (the outer, fleshy part of the upper leg) is a natural second choice, especially if you find the abdomen uncomfortable. The upper arm is perfectly acceptable but can be trickier to reach and pinch for a single-handed injection; some people ask a partner or carer to help with that site.
The NHS guidance on tirzepatide (Mounjaro) confirms these three sites and notes that injections should go into the fatty layer under the skin, not into a vein or muscle. Your pen's Patient Information Leaflet includes diagrams; it is worth reading through those before your first dose. If you have already started treatment and want to compare notes on technique, the guidance on where to put weight loss injections covers the practicalities in more detail.
The choice of site matters less than the habit of rotating. Injecting repeatedly into exactly the same spot can cause lipodystrophy, small, hardened or indented areas under the skin where the tissue has been disrupted. This is not dangerous, but it can slow absorption and make injections less comfortable over time.
A simple rotation system keeps things consistent without needing to remember a complex schedule. Many people divide the abdomen into four rough quadrants and move clockwise each week; others alternate between the abdomen and thigh. Either approach works, as long as you are not returning to the identical spot more than once every four weeks or so.
Within a single site, aim to move at least 1–2 cm from last week's entry point. If a spot feels tender, bruised, or shows a visible lump, skip it until it has settled. Cleaning the area beforehand with an alcohol swab and allowing it to dry fully before injecting also reduces the chance of skin reactions.
Injection-site reactions (redness, itching, a small bruise) are among the more commonly reported side effects in clinical trials for both Mounjaro and Wegovy. They are generally mild and transient. If a reaction is spreading, feels warm, or does not settle within a day or two, contact your prescriber.
Getting the injection right is mostly about preparation, not skill. Both Mounjaro and Wegovy pens are pre-filled and pre-set; there is no drawing up of medicine or complex assembly. A few consistent habits make each weekly dose as uneventful as possible.
Take your pen out of the fridge and leave it at room temperature for about 30 minutes before injecting, a cold injection can sting more. Storage itself must follow the SmPC: refrigerated at 2–8°C, with a limited window permitted at room temperature. The exact room-temperature allowance differs between Mounjaro and Wegovy and between pen formats, so always refer to your specific leaflet rather than a general figure.
Pinch a fold of skin at the chosen site before pressing the pen against it. Once the dose is delivered, hold the pen in place for a few seconds before removing it. Used pens and needles must be disposed of safely in a sharps container, never in a household bin. Your local council or GP surgery can advise on collection arrangements.
Our prescribers at nume are available seven days a week to answer technique questions after you start. If you are still weighing up which treatment fits your situation, a look at the range of weight loss injections available in the UK gives useful context before you consult.
Most people settle into a comfortable routine within the first two or three weeks. A few situations do warrant a conversation with your clinical team rather than a self-directed adjustment.
If you are injecting into the abdomen and notice persistent skin changes (not just a small bruise but a thickened area that does not resolve) mention it at your next review. The same applies if every site feels sore consistently; sometimes a slower dose-increase schedule eases things. People who take oral contraceptives should note that tirzepatide specifically may reduce pill absorption during the first four weeks of treatment and for four weeks after each dose increase, and adding a non-oral contraceptive method during those windows is advised by the NHS. That is not an injection-site question, but it is the kind of practical detail a prescriber covers during a structured review rather than something to manage alone.
If you are thinking about starting treatment and want to understand the full clinical picture (eligibility, what the process looks like, what our prescribers check) you can find information on where to access weight loss injections through a regulated pharmacy. Cost is a common follow-up question at that point, and the weight loss injection cost page sets out what a legitimate private price typically includes. For a broader overview of how these treatments work before exploring costs, our page on weight loss injections explains the different options and what to expect from the process.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.